AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24996984
Drug: BAL-directed therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAL-directed therapy
Trial: 18633127
Drug: Allopurinol 600
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Allopurinol 600 mg/day (stage 2)
Trial: 18633127
Drug: Benzbromarone 200
RxNorm normalized name: benzbromarone
DrugBank: Benzbromarone (DB12319)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzbromarone 200 mg/day (stage 2)
Trial: 17353072
Drug: Probiotic treatment
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic treatment (Lactobacillus rhamnosus GG and LC705, Bifidobacterium breve 99 and Propionibacterium freudenreichii JS)
Trial: 29101841
Drug: One Session
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One Session Treatment (OST)
Trial: 28145413
Drug: Lovaza (omega-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovaza (omega-3 preparation)
Trial: 20043831
Drug: Daily activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily activity monitoring and distance counselling (12 months)
Trial: 17295588
Drug: Nicotine (0.60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (0.60 mg)
Trial: 17295588
Drug: Nicotine (0.60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (0.60 mg) and Expectancy
Trial: 11506058
Drug: 3.0 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.0 g/day phytosterols
Trial: 11506058
Drug: 6.0 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.0 g/day phytosterols
Trial: 11506058
Drug: 9.0 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9.0 g/day phytosterols
Trial: 11506058
Drug: 0.0 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.0 g/day phytosterols (control)
Trial: 27060991
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (CT) with silodosin at 8 mg/day and propiverine at 20 mg/day
Trial: 27060991
Drug: α1-blocker monotherapy
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: α1-blocker monotherapy (MT) with silodosin at 8 mg/day
Trial: 25702095
Drug: 15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/kg tranexamic acid (TXA) in 100 mL normal saline solution
Trial: 20048210
Drug: varenicline (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: varenicline (1 mg twice daily)
Trial: 1611645
Drug: Amoxicillin/clavulanate (500/125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate (500/125 mg thrice daily)
Trial: 1505371
Drug: Loracarbef (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loracarbef (400 mg twice daily)
Trial: 20718545
Drug: Daily prayer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily prayer for 4 weeks
Trial: 11923036
Drug: Each 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Each 100 ng/ml increase in sICAM‐1 concentration
Trial: 8197035
Drug: Ketorolac tromethamine
RxNorm normalized name: Ketorolac Tromethamine
DrugBank: Ketorolac (DB00465)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketorolac tromethamine 10 mg
Trial: 2656777
Drug: Morphine sulfate
RxNorm normalized name: Morphine Sulfate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine sulfate 10 mg
Trial: 28103714
Drug: Gaze‐contingent music
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gaze‐contingent music reward therapy
Trial: 19801040
Drug: PM101 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PM101 (50 mg/ml, bolus push)
Trial: 19801040
Drug: Standard loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard loading dose of AIV (150 mg, infused at 1.5 mg/ml over 10 minutes)
Trial: 19801040
Drug: Rapid loading
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid loading dose of AIV (150 mg, infused undiluted at 50 mg/ml over 15 seconds)
Trial: 16412749
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and low molecular weight heparin treatment in women with APS
Trial: 31270774
Drug: Active therapy
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active therapy
Trial: 8203857
Drug: Standard antimicrobial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antimicrobial prophylaxis (400 mg of norfloxacin orally three times a day, 200 mg of fluconazole orally once a day, and 5 mg of acyclovir per kg of body weight i.v. q12h) without gram-positive prophylaxis.
Trial: 30805949
Drug: NGM282 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NGM282 1 mg
Trial: 29717197
Drug: NGM282 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NGM282 6 mg
Trial: 29717197
Drug: NGM282 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NGM282 (1 mg and 6 mg)
Trial: 24039194
Drug: 12 hours
RxNorm normalized name: PATCH, TRANSDERMAL 12 HOURS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 hours of intravenous prehydration before HDMTX infusion
Trial: 24039194
Drug: 4 hours
RxNorm normalized name: PATCH, TRANSDERMAL 24 HOURS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 hours of intravenous prehydration before HDMTX infusion
Trial: 22743321
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg L and 1 mg Z supplementation
Trial: 19078818
Drug: Subcutaneous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous lidocaine (0.5 ml of 2% lidocaine 2 min before arterial puncture)
Trial: 10517342
Drug: Modified radical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified radical mastectomy or breast conservation treatment
Trial: 7739851
Drug: 0.2 g
RxNorm normalized name: methionine 0.2 gram ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 g caffeine administered orally
Trial: 7739851
Drug: Caffeine elimination
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine elimination measured at 12 hours post-administration
Trial: 12700955
Drug: Felodipine ER
RxNorm normalized name: Felodipine ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine ER 10 mg once daily
Trial: 340131
Drug: Tinidazole (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinidazole (2 g once daily for 3 consecutive days)
Trial: 340131
Drug: Metronidazole (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (2 g once daily for 3 consecutive days)
Trial: 30198451
Drug: Immersive virtual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immersive virtual reality plus morphine
Trial: 24755130
Drug: Morphine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine alone
Trial: 14675406
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous methotrexate (HDMTX) (6-8 g/m2) with intrathecal methotrexate (ITMTX)
Trial: 11703217
Drug: Problem-based health
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem-based health education program (n=18), multidisciplinary approach, cognitive behavioral therapy exercises, 7 sessions over 5 months
Trial: 28691866
Drug: Venetoclax 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venetoclax 600 mg multiple ascending dose
Trial: 28691866
Drug: Venetoclax (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venetoclax (various doses)
Trial: 24000874
Drug: Continuous or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous or intermittent users of other antihypertensive drugs
Trial: 24000874
Drug: Never‐users of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Never‐users of antihypertensive drugs
Trial: 20621401
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium 75 mg intramuscularly
Trial: 17081832
Drug: Cocoa flavanol-enriched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocoa flavanol-enriched snack bar containing 1.5 g phytosterol
Trial: 3282531
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oral pimobendane (UD-CG 115)
Trial: 19629514
Drug: Rheopheresis treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rheopheresis treatment (10 treatments within 17 weeks)
Trial: 16202012
Drug: Rheopheresis treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rheopheresis treatment
Trial: 26638037
Drug: Weekly follow‐up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly follow‐up phone calls in addition to scripted diagnosis and inpatient psychiatry consultation (n=15)
Trial: 25546486
Drug: Delayed VT
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Delayed VT therapy ICD programming (arm C)
Trial: 25546486
Drug: First inappropriate
RxNorm normalized name: Cow first milk
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First inappropriate ICD therapy
Trial: 25546486
Drug: First appropriate
RxNorm normalized name: Cow first milk
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First appropriate ICD therapy
Trial: 17023234
Drug: Once-Daily Controlled-Release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-Daily Controlled-Release Carvedilol CR
Trial: 17023234
Drug: Twice-Daily Immediate-Release
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-Daily Immediate-Release Carvedilol IR
Trial: 19242664
Drug: Etanercept (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept (25 mg twice weekly)
Trial: 6381314
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (b.i.d. and q.i.d.)
Trial: 29934701
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (diosmin in combination with hesperidin, diosmetin, isoroifolin, and linarin in purified micronized fraction)
Trial: 26910697
Drug: Postoperative arnica
RxNorm normalized name: ARNICA
DrugBank: Arnica montana flower (DB14343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative arnica cream treatment (Group 1, n = 36)
Trial: 26910697
Drug: Postoperative mucopolysaccharide
RxNorm normalized name: sulfated mucopolysaccharides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative mucopolysaccharide polysulfate cream treatment (Group 2, n = 36)
Trial: 24281981
Drug: Carbetocin (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbetocin (initial dose 10 μg, increments/decrements of 5 μg)
Trial: 20357486
Drug: Dpg-Pol extracts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dpg-Pol extracts (100 HEPL/ml) administered with 6 up-dosing and monthly maintenance injections for 1 year
Trial: 18478481
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (LD, 1.5 g NS day (‐1))
Trial: 18478481
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (HD, 3.0 g NS day (‐1))
Trial: 31973700
Drug: Levobupivacaine (L)
DrugBank: Levobupivacaine (DB01002)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levobupivacaine (L)
Trial: 8660169
Drug: Antiviral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiviral treatment (specific agents not detailed)
Trial: 2874663
Drug: Celiprolol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiprolol (200 mg daily)
Trial: 11561116
Drug: Nifedipine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (40 mg daily)
Trial: 27419856
Drug: Group medical
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group medical visits (GMVs) incorporating CAM therapies (mindfulness techniques, movement, guided imagery, relaxation training, yoga, qigong, t'ai chi)
Trial: 24144212
Drug: 10 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/kg/day hydroxyurea (HU)
Trial: 24144212
Drug: 20 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/kg/day hydroxyurea (HU)
Trial: 8636753
Drug: Toremifene (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toremifene (60 mg orally per day for 3 years)
Trial: 8636753
Drug: Tamoxifen (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (20 mg orally per day for 3 years)
Trial: 3863624
Drug: PGE2 gel
RxNorm normalized name: PGE2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: PGE2 gel (0.5 mg dose)
Trial: 15618687
Drug: Cefdinir 200
RxNorm normalized name: Cefdinir
DrugBank: Cefdinir (DB00535)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefdinir 200 mg alone (Study 1)
Trial: 27933399
Drug: Nurse-guided clinical
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-guided clinical decision support system for rehydration treatment
Trial: 22256652
Drug: Infantile Tuina
RxNorm normalized name: Dolofin Infantil
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infantile Tuina treatment (tonifying Pijing, clarifying Dachangjing, Tuina on Lanmen, Qi, Fu Shangqijiegu, Guiwei, Zusanli (ST 36), Banmen, Sanguan)
Trial: 28482621
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no therapy)
Trial: 22538270
Drug: Gemfibrozil (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil (600 mg b.i.d)
Trial: 22538270
Drug: Brivaracetam (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brivaracetam (150 mg) alone
Trial: 19969437
Drug: Pimozide formulation
RxNorm normalized name: Pimozide
DrugBank: Pimozide (DB01100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pimozide formulation 1
Trial: 19969437
Drug: Pimozide formulation
RxNorm normalized name: Pimozide
DrugBank: Pimozide (DB01100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pimozide formulation 2
Trial: 18768019
Drug: Oral-B Sensitive
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral-B Sensitive Advantage (OBSA)
Trial: 1804650
Drug: AS-4370 5
RxNorm normalized name: remifentanil
DrugBank: Remifentanil (DB00899)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AS-4370 5 mg
Trial: 1804650
Drug: AS-4370 10
RxNorm normalized name: octreotide
DrugBank: Octreotide (DB00104)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: AS-4370 10 mg
Trial: 25365188
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of 50 mg·kg(‐1) silybin for 15 consecutive days
Trial: 25365188
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 50 mg·kg(‐1) silybin
Trial: 20372991
Drug: Azithromycin capsules
RxNorm normalized name: Azithromycin Capsules
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin capsules (fed state)
Trial: 17963629
Drug: Valsartan/HCTZ 80/12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan/HCTZ 80/12.5 mg once daily
Trial: 2017535
Drug: Dexamethasone 1.5
RxNorm normalized name: dexamethasone 1.5 MG
DrugBank: Dexamethasone (DB01234)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone 1.5 mg
Trial: 6637819
Drug: Intravenous hydralazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydralazine 0.15 mg/kg
Trial: 6637819
Drug: Furosemide 1
RxNorm normalized name: furosemide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide 1 mg/kg after ISDN
Trial: 24245807
Drug: internet-delivered cognitive
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: internet-delivered cognitive behavioral therapy (ICBT) for 10 weeks
Trial: 21148119
Drug: Topiramate 64
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate 64 mg/day
Trial: 18308157
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment without distal protection (n = 314)
Trial: 9526578
Drug: Fenretinide (4-HPR)
RxNorm normalized name: FENRETINIDE
DrugBank: Fenretinide (DB05076)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenretinide (4-HPR) at a dose of 200 mg per os every day for 5 years
Trial: 8345067
Drug: Short protocol
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short protocol (buserelin 1 mg/day intranasally from cycle day 1 and HMG 2 ampoules/day from day 3 until HCG administration)
Trial: 8345067
Drug: Long protocol
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long protocol (buserelin 1 mg/day intranasally from cycle day 1 for at least 14 days, then HMG 2 ampoules/day added)
Trial: 29455894
Drug: Cognitive behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioural therapy (CBT) for MS-related fatigue, 16-week treatment.
Trial: 27498916
Drug: Saline inhalation
RxNorm normalized name: Broncho Saline Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline inhalation (control)
Trial: 23333044
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of L-arginine (500 mg, twice daily for two weeks)
Trial: 8771664
Drug: Interferons (alpha‐2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferons (alpha‐2 and gamma‐interferons) administered in daily doses of 15,000‐25,000 IU/kg and 1500‐2500 IU/kg, respectively.
Trial: 1614182
Drug: Inhaled amiloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled amiloride (10(‐3)M), twice daily for two months
Trial: 1614182
Drug: 0.9% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% saline (control), twice daily for two months
Trial: 3886209
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose AVP infusion (75 pmol/min)
Trial: 20233185
Drug: Lercanidipine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lercanidipine (2 mg)
Trial: 20233185
Drug: Amlodipine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (1 mg)
Trial: 16649829
Drug: Mirtazapine treatment
RxNorm normalized name: Mirtazapine
DrugBank: Mirtazapine (DB00370)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mirtazapine treatment
Trial: 9000826
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium (high and low doses)
Trial: 16249073
Drug: Agomelatine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agomelatine (25 mg and 50 mg/day)
Trial: 10733168
Drug: CHIRON CMV
RxNorm normalized name: opopanax chironium whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHIRON CMV gB subunit vaccine combined with MF59 adjuvant
Trial: 8737128
Drug: Amoxycillin 1
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin 1 g tid plus ofloxacin 200 mg bid
Trial: 20937045
Drug: rifaximin 1200
RxNorm normalized name: Rifaximin
DrugBank: Rifaximin (DB01220)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rifaximin 1200 mg/day plus partially hydrolysed guar gum 5 g/day for 10 days
Trial: 16326121
Drug: Salmeterol/fluticasone combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/fluticasone combination (50/250 mcg by Diskus) for 1 week and a single dose of salmeterol/fluticasone immediately before allergen challenge (T3)
Trial: 16326121
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment and a single dose of placebo immediately before allergen challenge (T1)
Trial: 16326121
Drug: Salmeterol/fluticasone combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/fluticasone combination (50/250 mcg by Diskus) for 1 week
Trial: 12952110
Drug: Omalizumab (at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omalizumab (at least 0.016 mg/kg/IgE [IU/mL] per 4 weeks)
Trial: 7497558
Drug: diltiazem 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diltiazem 0.3 mg.kg‐1 (Group D, n = 12)
Trial: 2023098
Drug: Ranitidine, 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine, 600 mg daily for 28 days
Trial: 8707167
Drug: Enoxaparin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (40 mg)
Trial: 19640331
Drug: Simvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (40 mg/d for 4 weeks)
Trial: 17244765
Drug: Alprazolam, Olanzapine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam, Olanzapine, Risperidone (test drugs)
Trial: 14699269
Drug: Prolotherapy injections
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolotherapy injections (20% glucose/0.2% lignocaine)
Trial: 7502546
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (FO) supplementation (11 g/day)
Trial: 7502546
Drug: Corn oil
RxNorm normalized name: Corn Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn oil (CO) supplementation (11 g/day)